Repopulation of cancer cells during therapy: an important cause of treatment failure (Q36167592)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Repopulation of cancer cells during therapy: an important cause of treatment failure	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

1 reference

Europe PubMed Central

Repopulation of cancer cells during therapy: an important cause of treatment failure (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

2

object named as

Ian F Tannock

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

author name string

John J Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

language of work or name

0 references

publication date

1 July 2005

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Nature Reviews Cancer

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

516-525

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Tumour stem cells--the evidence and the ambiguity

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

The hazard of accelerated tumor clonogen repopulation during radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Post-irradiation proliferation kinetics of a serially transplanted murine adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Cell population kinetics of the rhabdomyosarcoma R1H of the rat after single doses of X-rays

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Influence of treatment time on the response of rat rhabdomyosarcoma R1H to fractionated irradiation

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Influence of dose per fraction and overall treatment time on the response of pulmonary micrometastases of the R1H-tumour to fractionated irradiation

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Changes in TCD50 as a measure of clonogen doubling time in irradiated and unirradiated tumors

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Tumour cell repopulation during fractionated radiotherapy: Correlation between flow cytometric and radiobiological data in three murine tumours

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Repopulation kinetics during fractionated irradiation and the relationship to the potential doubling time, Tpot

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlates with reoxygenation.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

The effects of clamping and reoxygenation on repopulation during fractionated irradiation

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Repopulation of moderately well-differentiated and keratinizing GL human squamous cell carcinomas growing in nude mice

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

The effect of the overall treatment time of fractionated irradiation on the tumor control probability of a human soft tissue sarcoma xenograft in nude mice

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Cell kinetics and repopulation parameters of irradiated xenograft tumours in SCID mice: comparison of two dose-fractionation regimens

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Repopulation between radiation fractions in human melanoma xenografts

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Clinical evidence for tumor clonogen regeneration: interpretations of the data.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Local control of carcinoma of the tonsil by radiation therapy: An analysis of patterns of fractionation in nine institutions

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: an interim report

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Dose fractionation and tumour repopulation in radiotherapy for bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

The effect of treatment duration in the local control of cervix cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

How fast is repopulation of tumor cells during the treatment gap?

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Transmutability of dose and time. Commentary on the first report of RTOG 90003 (K. K. FU et al.)

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Tumour volume response, initial cell kill and cellular repopulation in B16 melanoma treated with cyclophosphamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Improved treatment of a brain-tumor model. Part 1: Advantages of single- over multiple-dose BCNU schedules

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Dynamics of tumor cell clonogen repopulation in a murine sarcoma treated with cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Tumor resistance to therapy: a genetic or kinetic problem?

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Rapid tumor cell proliferation after induction chemotherapy in oropharyngeal cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Assessment of tumor cell repopulation after chemotherapy for advanced ovarian cancer: pilot study

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Rapid repopulation in radiotherapy: a debate on mechanism. The phantom of tumor treatment--continually rapid proliferation unmasked

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Three A's of repopulation during fractionated irradiation of squamous epithelia: Asymmetry loss, Acceleration of stem-cell divisions and Abortive divisions

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Changes in the rate of repopulation during multifraction irradiation of mouse skin

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Proliferation and micromilieu during fractionated irradiation of human FaDu squamous cell carcinoma in nude mice

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

The effect of ionizing radiation on signal transduction: antibodies to EGF receptor sensitize A431 cells to radiation

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Molecular mechanisms of radiation-induced accelerated repopulation

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose ionizing radiation in A431 human squamous carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Calcium-dependent stimulation of mitogen-activated protein kinase activity in A431 cells by low doses of ionizing radiation.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

The relative role of ErbB1-4 receptor tyrosine kinases in radiation signal transduction responses of human carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Relationship between cyclin D1 expression and poor radioresponse of murine carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Repopulation of tumour cells between cycles of chemotherapy: a neglected factor

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Proliferation-associated oxygen consumption and morphology of tumor cells in monolayer and spheroid culture

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Distribution and activity of antineoplastic drugs in a tumor model

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Delivery of molecular and cellular medicine to solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Tumor physiology and drug resistance

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Microregional effects of gemcitabine in HCT-116 xenografts

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Biologic basis for altered fractionation schemes.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Accelerated fractionation in the radiation treatment of head and neck cancer. A critical comparison of different strategies

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Conventional and Superfractionated Radiation Therapy in Burkitt's Lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Planned and unplanned gaps in radiotherapy: the importance of gap position and gap duration

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leu

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Accelerated versus standard cyclophosphamide, epirubicin and 5-fluorouracil or cyclophosphamide, methotrexate and 5-fluorouracil: a randomized phase III trial in locally advanced breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Meta-analyses in head and neck squamous cell carcinoma. What is the role of chemotherapy?

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Treatment of cancer with radiation and drugs

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Applying radiobiological principles to combined modality treatment of head and neck cancer—The time factor

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin C and 5 fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal squamous carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Tirapazamine, Cisplatin, and Radiation versus Fluorouracil, Cisplatin, and Radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02).

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Radiation with concurrent late chemotherapy intensification ('chemoboost') for locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Combined-modality treatment of solid tumors using radiotherapy and molecular targeted agents

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

The molecular genetics of prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Effects of the mammalian target of rapamycin inhibitor CCI-779 used alone or with chemotherapy on human prostate cancer cells and xenografts

1 reference

https://api.crossref.org/works/10.1038%2FNRC1650

31 March 2020

Identifiers

10.1038/NRC1650

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36167592&oldid=2198290150"